Innovating Works
IM2PACT: Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics IM2PACT Into The B... ARTEMIS BIOSUPPORT B.V. participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage The overall aim is to further the understanding of the BBB in health and disease states towards the development of innovative brain delivery...
2018-12-14 - 2024-12-31 | Financiado
COMPARE: COllaborative Management Platform for detection and Analyses of Re emerging and foodborne outbreak... ARTEMIS BIOSUPPORT B.V. participó en un H2020: H2020-PHC-2014-2015 COMPARE aims to harness the rapid advances in molecular technology to improve identification and mitigation of emerging infectious diseases...
2014-11-28 - 2019-11-30 | Financiado
ZAPI: Zoonotic Anticipation and Preparedness Initiative ARTEMIS BIOSUPPORT B.V. participó en un FP6: Emerging infectious diseases are occurring at increasing frequency in Europe and other regions of the world, having profound impacts on publ...
2015-03-01 - 2020-02-29 | Financiado
FLUCOP: Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protect... ARTEMIS BIOSUPPORT B.V. participó en un FP6: Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Infl...
2015-03-01 - 2020-02-29 | Financiado
ZAPI: Zoonotic Anticipation and Preparedness Initiative ARTEMIS BIOSUPPORT B.V. participó en un FP7: Emerging infectious diseases are occurring at increasing frequency in Europe and other regions of the world, having profound impacts on publ...
Financiado
ASKLEPIOS: Advanced Studies towards Knowledge on Lyssavirus EncephalitisPathogenesis Improving Options for Surv... ARTEMIS BIOSUPPORT B.V. participó en un FP7: The overall aim of ASKLEPIOS is to unravel and increase our understanding of the mechanisms that govern pathogenesis of rabies virus (RABV)...
Financiado
FLUCOP: Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protect... ARTEMIS BIOSUPPORT B.V. participó en un FP7: Background: Influenza viruses cause annual epidemic and occasional pandemics, both of which induce significant morbidity and mortality. Infl...
Financiado
FLUNIVAC: InFLUenza virus UNIVersal VACcine development program ARTEMIS BIOSUPPORT B.V. participó en un FP7: "Effectively protecting the general population from seasonal and pandemic influenza has proven to be a challenge, since influenza viruses co...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.